Yuwen Cai

879 citations
13 papers · 354 indexed · 1 hit paper · h-index 7
Topics
Breast Cancer Treatment Studies (4 papers)Advanced Breast Cancer Therapies (2 papers)Pharmacology and Obesity Treatment (2 papers)
Partner nations
ChinaCzechiaLuxembourg

In The Last Decade

Yuwen Cai

11 papers receiving 350 citations

Hit Papers

Breast cancer: pathogenesis and treatments2025202620254080120

Peers

Yuwen Cai
Comparison fields: 5 of 83
  • Molecular Biology 133
  • Oncology 118
  • Cancer Research 111
  • Pulmonary and Respiratory Medicine 52
  • Genetics 30
Replace Iwao Shimomura with:
Iwao Shimomura Japan
Dawn M. Albrecht United States
Julie Leclerc France
Heather L. Blackburn United States
Yasuko Kikuchi Japan
Lukas Klameth Austria
Yevgeniy Gindin United States
Tianyu Qin China
Alicja Puszkiel France
Ravat Panvichian Thailand
Yuwen Cai relative to Iwao Shimomura Japan Iwao Shimomura's profile →
Citations per field
00.5×4.5×
Iwao Shimomura · 1×
Citations per year

Countries citing papers authored by Yuwen Cai

Since Specialization
Citations

This map shows the geographic impact of Yuwen Cai's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Yuwen Cai with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Yuwen Cai more than expected).

Fields of papers citing papers by Yuwen Cai

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Yuwen Cai. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Yuwen Cai. The network helps show where Yuwen Cai may publish in the future.

Co-authorship network of co-authors of Yuwen Cai

This figure shows the co-authorship network connecting the top 25 collaborators of Yuwen Cai. A scholar is included among the top collaborators of Yuwen Cai based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Yuwen Cai. Yuwen Cai is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

13 of 13 papers shown
#WorkIndexed citations
1
Breast cancer: pathogenesis and treatmentsbreakdown →
145
2 0
3 0
4 1
5 90
6 6
7 20
8 37
9 4
10 11
11 29
12 3
13 8

About Yuwen Cai

Yuwen Cai is a scholar working on Cancer Research, Public Administration and Modeling and Simulation, having authored 13 papers that have together received 354 indexed citations. Recurring topics across this work include Breast Cancer Treatment Studies (4 papers), Advanced Breast Cancer Therapies (2 papers) and Pharmacology and Obesity Treatment (2 papers). The work is most often cited by research in Cancer Research (111 citations), Oncology (118 citations) and Modeling and Simulation (13 citations). Yuwen Cai has collaborated with scholars based in China, Czechia and Luxembourg. Frequent co-authors include Ke‐Da Yu, Zhi‐Ming Shao, Yufei Chen, Xin Xiong, Cuicui Liu, Leiping Wang, Lewei Zheng, Yu‐Qiang Ding, Liang Huang and Gaosi Xu. Their work appears in journals such as Cancer, Nanoscale and Frontiers in Immunology.

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Rankless by CCL
2026